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Received January 31, 2011; accepted September 1, 2011AbstractBackground: Analysis of the coronary artery calcium levels usually provides important information that can be used in patient prognosis and
stratification of treatment when coronary artery disease is suspected. However, plaques, with or without significant stenosis, have been reported
in patients without coronary artery calcium. The aim of this study was to determine the frequency and risk factors of the development of
coronary artery plaques in individuals with a zero calcium score.
Methods: Analysis of coronary artery calcium levels and coronary computed tomography angiography (CTA) were performed using 64-slice
computed tomography (CT). The demographic data, clinical risk factors, and imaging features of 519 consecutive patients (54  10 years,
male:female ratio of 56:44) were retrospectively analyzed. The presence of plaques and the degree of the resulting stenosis were recorded.
Descriptive, univariate, and multivariate analyses were carried out to identify the frequency and risk factors associated with the presence of
coronary artery plaques.
Results: Among 66 patients, 82 coronary arteries were found to have plaques, and six coronary arteries showed significant stenosis. Univariate
analysis showed that an age greater than 55 years, male gender, a body mass index (BMI) of more than 27, hypertension, and diabetes mellitus
are significant factors associated with the development of coronary artery plaques. Multivariate logistic regression analysis showed that an age
over 55 years ( p ¼ 0.012, OR ¼ 2.13, 95% C.I. ¼ 1.18e3.84) and BMI greater than 27 ( p ¼ 0.026, OR ¼ 2.01, 95% C.I. ¼ 1.09e3.72) are
independent factors associated with the presence of plaques in patients with a zero calcium score.
Conclusion: The results of this study show that plaques are present in a significant proportion of individuals with a zero coronary artery calcium
score. In addition, advanced age and obesity are risk factors associated with the development of plaques.
Copyright  2011 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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The use of noninvasive coronary artery imaging has grad-
ually gained popularity for the management of patients known
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doi:10.1016/j.jcma.2011.11.001of traditional functional imaging techniques. Coronary artery
calcium (CAC) scoring has been studied for almost two
decades. Although widely disputed at first, many studies have
shown that the calcium score is directly related to the clinical
prognosis of CAD; in addition, it can provide prognostic
information that can be used with traditional risk stratification
methods.1,2 The absence of calcium may exclude obstructive
CAD and help identify patients who do not require further
testing.3hinese Medical Association. All rights reserved.
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lenged by the recent introduction of coronary multi-detector
computer tomography angiography (CTA), which allows
better visualization of the lumen and vessel wall and, thus,
improves the detection of calcified and noncalcified plaques.4
Patients with acute coronary syndrome have a higher propor-
tion of noncalcified plaques than calcified plaques. However,
the absence of calcium does not necessarily indicate the
absence of atherosclerosis. Henneman et al reported that 39%
of patients who presenting with the acute coronary syndrome
have a zero CAC score.5
The clinical relevance and implications of noncalcified
plaques observed on CTA remain largely unknown. Moreover,
the exact prevalence of noncalcified plaques, in the absence of
calcium, also remains to be determined. The goal of this study
was to determine the frequency of noncalcified plaques in the
absence of CAC and to identify the factors associated with the
presence of atherosclerotic plaques in patients with a zero
calcium score.
2. Methods
A retrospective study was conducted on consecutive
patients who required both a determination of their coronary
calcium score and coronary CTA from May 2008 to December
2009 at 3,000-bed tertiary referral medical center in northern
Taiwan. Informed consent was obtained from all patients.
Patients with a zero calcium score were selected for subse-
quent analysis. Medical histories and laboratory data,
including risk factors such as smoking, symptoms, hyperten-
sion, and dyslipidemia, were reviewed and recorded. Patients
were classified as either a nonsmoker or a current smoker.
Dyslipidemia was recorded if there was history of a high-
density lipoprotein (HDL) level of less than 40 mg/dL and
a triglyceride level of more than 150 mg/dL. Hypertension was
recorded if blood pressure was equal to or greater than 130/
85 mmHg or if the patient was taking medication for hyper-
tension. The body mass index (BMI) was calculated from the
body weight and height measured on the day of the exami-
nation. Symptoms were recorded as follows: chest pain
symptoms, nonchest pain symptoms, or no symptoms. The risk
category for coronary heart disease was determined and
patients were assigned to low-risk, intermediate-risk, or high-
risk groups.6
3. CT scanning protocol
The Computed tomography (CT) scanning protocol was as
follows: blood pressure and heart rate were measured and
beta-blockers, with or without a calcium channel blocker, were
given to all patients with an initial heart rate faster than 65
beats per minute, if there were no contraindications (e.g.,
patients who were unable to maintain a heart rate of less than
65 beats per minute or did not undergo CT scanning).
All CT scans were performed using a 64-slice Multi-
detector CT (Aquilion 64, Toshiba Medical Systems, Otawara-
shi, Japan); a prospective Electrocardiogram (ECG)-gatedconventional axial scan with collimation set to
4.0  3.0 mm was triggered at 75% of the R-R interval. The
scanning sequence began approximately 1 cm above the left
main coronary artery. The CT scan parameters were set to
120 kV and 300 mA. A temporal resolution of 230 millisec-
onds was achieved by using the half-scan reconstruction
method with a 350-millisecond gantry rotation time. The table
advanced 12 mm per gantry rotation, providing contiguous 3-
mm sections. Patients were asked to hold their breath for
10e15 seconds, depending on their heart rate, in order to
complete the scan.
Coronary CTAwas performed by retrospective-gated helical
scanning with the following parameters: 64  0.5 mm colli-
mation, 350-millisecond gantry rotation time, 120e135 kV, 111
effective mAs, and an image-acquisition time of 7e12 seconds.
The bolus-trackingmethodwas used after the injection a total of
70e105 mL of iodinated contrast medium (Iopamiro370;
Bracco Imaging SpA, Milan, Italy) at a rate of 5 mL/second
followed by 50 mL of normal saline at a rate of 5.5 mL/second.
The workstation automatically selected the best phase; if the
image quality was suboptimal, we manually reconstructed
a phase with the best possible image quality, which was
reconstructed into 0.3 mm-thick images.
4. Image analysis
The reconstructed CT images were then transferred to
a workstation (Aquarius workstation, version 3.2.2.1; TeraR-
econ, Inc., San Mateo, CA, USA). Two radiologists (C.K.C.
and Y.S.K.) independently analyzed the images. First, the
image quality of the CT coronary angiography was semi-
quantitatively evaluated using a 4-point grading scale. An
axial image with a score of 4 corresponded to excellent image
quality with no motion artifacts, a score of 3 corresponded to
good image quality with minor motion artifacts or slight
blurring of the delineation of a vessel, a score of 2 corre-
sponded to fair image quality with moderate motion artifacts,
and a score of 1 corresponded to poor image quality with
severe motion artifacts or obvious stair-step artifacts. A patient
with an image quality score of 1 (of any segment) was
excluded from subsequent analysis. The CAC score was
calculated using the Agatston algorithm.7 The presence of
plaques and stenosis were evaluated using multiplanar recon-
struction of the individual coronary segment; this classification
method was adopted and modified according to the method
previously described by Austen et al.8 Coronary plaques were
defined as discrete structures with an area greater than 1 mm2
that was within and/or adjacent to the coronary artery lumen
and surrounded by the pericardium.9 Plaques were recorded as
present or absent. If a plaque was present, it was further
characterized as soft, mixed, or calcified. Soft plaques con-
tained no calcification, mixed plaques contained both soft and
calcified components, and calcified plaques were almost
totally calcified. The percent stenosis was calculated as the
narrowest diameter of the lumen divided by the normal lumen
diameter of a nearby normal proximal portion of the same
segment. If there was a narrowed segment that was longer than
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the average of the nearby normal proximal and distal
segments. The percent stenosis was then divided into the
following groups: 0e19%, 20e49%, 50e69%, and equal to or
greater than 70%.
5. Statistical analysis
Descriptive and inferential statistics were analyzed using
SPSS version 17.0 (SPSS, Inc., Chicago, IL, USA). Patients
were divided into two groups: the advanced age group (con-
sisting of patients equal to or older than 55 years of age) and
the younger age group (consisting of patients less than 55
years of age). In addition, patients were divided according to
their BMI (two groups, those with BMI values greater than or
less than 27, respectively). The categorical variables are pre-
sented as frequencies and percentages, while continuous
variables are presented as the mean  standard deviation.
Univariate analysis was performed using the Chi-square test to
identify risk factors such as age, gender, smoking history,
diabetes mellitus, hypertension, dyslipidemia, and BMI in
order to predict the presence of soft plaques. A p value <0.05
was considered statistically significant. Multivariate analysis
was performed using logistic regression analysis in order to
identify factors associated with the presence of plaques.
6. Results
A total of 1172 individuals underwent coronary CTA from
May 2008 to December 2009. In addition, 62% of theseTable 1
Patient characteristics.
Characteristics (unit) Total
(n ¼ 519)
Age (y) 54  10
Male sex (%) 56.5
Clinical risk factors
Body mass index 24.8  3.6
Smoker (%) 22.4
Diabetes mellitus (%) 6.8
Hypertension (%) 35.6
Serum total cholesterol (mg/dL) 201  37
Serum HDL-C (mg/dL) 54  17
Serum LDL-C (mg/dL) 126  33
Triglyceride (mg/dL) 143  93
Serum creatinine (mg/dL) 0.89  0.22
Fasting plasma glucose (g/dL) 100  22
Dyslipidemia (%) 11.9
Symptoms (%)
No symptoms 62.5
Nonchest pain 24.8
Chest pain 12.7
Framingham risk category (%)
Low 60.6
Intermediate 36.4
High 3.0
values are mean.
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholpatients underwent coronary CTA in order to rule out CAD by
referral from a clinical physician; 35% of patients were highly
suspected of having coronary artery disease by the referring
physician and 3.2% for were referred for a post-stent
implantation evaluation. There were 37 patients who had at
least one stent in their coronary arteries; these patients were
excluded from this study. Among the remaining patients, 538
individuals had a CAC score of zero. Nine patients were
excluded due to incomplete demographic data, and one was
excluded due to the loss of reconstructed thin-section imaging
data. After nine more individuals were excluded due to a poor
image quality (images with a score of 1), 519 patients
remained available for analysis. This included 226 females
and 293 males; the average age of these patients was 54 years.
Among this group, 22.6% were nonsmokers and 35.6% were
diagnosed with hypertension. Chest pain was reported by
12.7% of patients. The majority of the patients (60.7%) with
chest pain underwent treadmill exercise testing, all of whom
obtained positive or equivocal results; 20% of these patients
also underwent thallium-201 perfusion testing. The demo-
graphic and baseline clinical characteristics are listed in
Table 1. For coronary CTA analysis, 66 patients had plaques
present in a total of 82 coronary arteries, including 21 right
coronary arteries, four left main coronary arteries, 48 left
anterior descending arteries, and nine circumflex arteries.
Mixed plaques were noted in 10 coronary arteries, and calci-
fied plaques were found in 15 coronary arteries. Two coronary
arteries were classified with high-grade stenosis (narrowing of
more than 70% of the lumen) (Fig. 1), and four coronary
arteries showed significant stenosis (narrowing of more thanWith plaque
(n ¼ 66)
No plaque
(n ¼ 453)
p
58  9 53  10 <0.001
71.2 54.3 0.009
26.0  4.4 24.6  3.5 0.005
26.2 21.8 0.431
13.3 5.8 0.031
49.2 33.6 0.014
202  34 202  38 0.868
53  17 55  17 0.651
123  26 127  34 0.436
154  93 142  92 0.342
0.94  0.28 0.89  0.20 0.051
113  43 99  22 0.017
12.0 11.9 0.972
60.6 62.8 0.418
30.3 24.0
9.1 13.2
41.3 63.4 <0.001
49.2 34.6
9.5 2.1
esterol.
Fig. 1. Coronary CTA of a 73-year-old male: (A) Curved multiplanar refor-
matted image showing a soft plaque in the left anterior descending artery
(LAD) with high-grade stenosis (arrow). (B, C) Cross-section of the multi-
planar reformatted image showing a soft plaque (arrowheads) and a markedly
narrowed lumen. (D) Catheter angiography shows high-grade stenosis of the
LAD (open arrow).
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arteries with significant stenosis caused by plaques, four had
soft plaques and two had mixed plaques.
Placement into the high-risk category of developing CAD
was significantly different between patients with nonzero and
zero calcium scores ( p < 0.001). Among patients with a zero
calcium score and coronary artery plaques, 9.5% were in the
high-risk group; only 2.1% of patients without plaques were in
the high-risk group. In patients with plaques, 49.2% were in
the intermediate-risk category and 41.3% were in the low-risk
group. Among patients without plaques, 34.6% were placed in
intermediate-risk group and 63.4% were placed in low-risk
group. The proportion of symptomatic individuals was
39.4% among patients with plaques 37.2% among patients
without plaques; there was no significant difference between
these groups ( p ¼ 0.733).
The results of the univariate analysis (Table 2) shows that
an age greater than 55 years, male gender, hypertension, dia-
betes mellitus, and a BMI of more than 27 presented at
significantly different levels in individuals with and without
coronary artery atherosclerotic plaques. For risk group strati-
fication of patients with a zero calcium score, the high-riskTable 2
Predictors of plaque determined by univariate analysis.
Characteristics
(n ¼ 519)
Wald
statistics
p Odds ratio
(95% CI)
Age (55 y) 6.86 0.009 2.04 (1.20e3.49)
Male sex 6.76 0.011 2.08 (1.18e3.66)
BMI  27 10.5 0.001 2.45 (1.42e4.22)
Smoker 0.62 0.432 1.27 (0.70e2.31)
Diabetes mellitus 4.38 0.036 2.48 (1.06e5.81)
Hypertension 5.92 0.015 1.92 (1.13e3.25)
Dyslipidemia 0.001 0.972 1.02 (0.40e2.56)
Symptomatic 0.12 0.734 1.10 (0.65e1.86)group had an odds ratio of 7.10 (95% Confidence interval
(CI) ¼ 2.34e21.5) for the development of coronary artery
plaques compared with the low-risk group. The intermediate-
risk group had an odds ratio of 2.19 (95% CI ¼ 1.25e3.82)
compared with the low-risk group. In the subgroup analysis of
female patients, postmenopausal women with a zero CAC
score did not show an increased incidence of plaques
compared with nonmenopausal women ( p ¼ 0.485). In the
analysis of significant stenosis in all patients with a zero
calcium score, there was an increased frequency of significant
stenosis in patients who were smokers ( p ¼ 0.025) and those
with diabetes mellitus ( p < 0.001). In the intermediate-risk
group, a BMI of more than 27 was a significant factor
present in patients with plaques compared with those without
plaques ( p ¼ 0.048). In addition, the presence of diabetes
mellitus was a significant factor present in patients at inter-
mediate risk of significant stenosis compared with those
without significant stenosis ( p ¼ 0.041).
The multivariate logistic regression analysis showed that an
age greater than 55 years ( p ¼ 0.012, OR ¼ 2.13, 95%
CI ¼ 1.18e3.84) and BMI greater than 27 ( p ¼ 0.026,
OR ¼ 2.01, 95% CIe1.09e3.72) were independent factors
associated with the presence of plaques in individuals with
a zero calcium score (Table 3). No risk factor associated with
significant stenosis was determined in the multivariate
analysis.
7. Discussion
CAC scoring has been gaining popularity for the stratifi-
cation of patients with CAD. Evidence shows that the absence
of CAC is associated with the very low risk of future cardio-
vascular events.10 Patients with coronary stenosis but without
CAC more often present with symptoms, such as chest pain,
than patients without coronary calcification. Hausleiter et al
reported that patients with noncalcified coronary atheroscle-
rotic plaques tend to have higher total cholesterol, low-density
lipoprotein, and C-reactive protein levels and are more likely
to have diabetes mellitus.11 However, in a recent study,
although the patients with noncalcified plaques were younger
than patients with calcified plaques, none of the identified risk
factors, including those described above, were significantly
different between the two groups.12 The goal of this study was
to determine the frequency of the risk factors associated with
atherosclerotic plaques in patients with a zero calcium score.
A considerable atheroma burden, including significant
stenosis, may be present in patients without coronaryTable 3
Predictors of plaque determined by multivariate analysis.
Characteristics
(n ¼ 519)
Wald
statistics
p Odds ratio
(95% CI)
Age (55 y) 6.28 0.012 2.13 (1.18e3.84)
Male sex 3.42 0.064 1.78 (0.97e3.27)
BMI  27 4.97 0.026 2.01 (1.09e3.72)
Diabetes mellitus 1.70 0.192 1.81 (0.74e4.43)
Hypertension 2.40 0.121 1.58 (0.89e2.80)
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coronary arterial wall and atherosclerotic plaques in order to
evaluate stenosis, thus guiding therapy in addition to the
calcium score. In this study, the frequency of atherosclerotic
plaques in patients with a zero calcium score was 13.3%;
1.3% of these patients had significant stenotic lesions. These
results are consistent with a previous study that reported
that 7e20% and 1e7% of patients had atherosclerotic plaques
and plaques causing significant stenosis, respectively.13e15
However, these results were lower than those of a previous
study, where 51% of the patients were reported to have
atherosclerotic plaques.16 These differences might be
explained by the following. The study population evaluated
for this report included only Chinese patients, whereas the
previous study, which reported an extremely high frequency of
plaques and obstructive lesions, had a study population that
mainly consisted of Caucasian patients.16 Most studies do not
specify the ethnic composition of their study populations.
While data does show that Chinese populations have a lower
risk of significant CAC levels than Caucasian populations,17,18
the association between ethnicity and frequency of plaques
remains to be determined, especially in patients with a zero
coronary calcium score.
In this study, BMI was one of the predictors of developing
coronary artery plaques in patients with a zero calcium score;
this finding is consistent with the results reported by Isma’eel
et al.19 In many studies on plaque frequency, the BMI was not
determined in patients with a zero calcium score.13e16 In this
study, patients with a BMI greater than 27 tended to have
a higher frequency of plaques, especially in the intermediate-
risk group. Further study is needed to clarify the association
between BMI and the frequency of plaque development, as
well as the effect of lowering the BMI has on the presence of
plaques, in this specific subgroup of patients.
The calcium score has been shown to be an independent
predictor of all-cause mortality.20 The absence of CAC has
been shown to be a good predictor of the low risk of adverse
events, both in symptomatic and asymptomatic individuals.
Budoff et al reported a very low risk for mortality in asymp-
tomatic individuals in a long-term follow-up study.21 In
addition, the absence of CAC is usually associated with a low
risk of coronary events in symptomatic individuals.10
However, coronary events have been reported to occur in
patients without significant CAC levels,22 and this finding has
been explained by the presence of vulnerable lipid-rich pla-
ques.23 The results of this study show that coronary artery
plaques can be found by coronary CTA in patients with a zero
calcium score.
CAC can be used as a stratification tool for the treatment of
abnormal levels of LDL cholesterol, especially in patients at
intermediate risk.24 Low CAC may lead physicians to pursue
less aggressive treatment options, which may not be appro-
priate because there is still the possibility that the patient may
have atherosclerotic plaques or obstructive lesions, even if the
CAC level is not measured. Given that the atherosclerotic
burden, as determined by CTA, can predict myocardial
ischemia better than CAC,25 adding coronary CTA to the CACscan may further refine patient treatment and prevent adverse
coronary events. However, the effect of lowering the choles-
terol level in patients with a zero calcium score, especially
those who are classified as intermediate risk, requires further
study.
This study had several limitations. There is no gold stan-
dard, such as intravascular ultrasound, that is currently avail-
able to confirm the presence of plaques. In addition, the
relatively small number of plaques that caused significant
stenosis prevented further investigation into the causes of the
obstructive lesions.
In conclusion, the results of this study show that a consid-
erable proportion (13.3%) of individuals with a zero CAC
score had coronary plaques and various risk factors, including
advanced age and a high BMI. These factors require further
study in order to determine the potential risk factors associated
with plaques in patients with a zero CAC score.References
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